Delivery Order SPE2DB24D2205-SPE2DB25FEHPE
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Takhzyro 300 mg/2 ml syringes with a ceiling value of $34,342.56. This firm fixed-price delivery order is scheduled for completion by September 15, 2025, and will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. The contract was awarded on a competitive basis with no set-aside designation. This delivery order operates under AmerisourceBergen Drug Corp's...
- The Defense Logistics Agency awarded a $34,342.56 delivery order to AmerisourceBergen Drug Corp on July 16, 2025, for the supply of Takhzyro 300 mg/2 ml syringes. The contract employs firm fixed pricing with no set-aside designation, indicating competitive award through open competition. Performance is scheduled for completion by August 6, 2025, and will be executed from the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract under...
- The Defense Logistics Agency awarded a $34,342.56 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Takhzyro 300 mg/2 ml syringes on April 25, 2025, with completion required by May 16, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The award was competitively granted with no set-aside designation, and...
- Amerisourcebergen Drug Corporation, operating as a division of Amerisourcebergen Corporation, has been awarded a $31,755.04 firm fixed price delivery order contract by the Defense Logistics Agency Troop Support Medical to provide TAKHZYRO 300 MG/2 ML syringes. Performance will take place in Conshohocken, Pennsylvania over a period spanning from June 28, 2023 through July 20, 2023. The Defense Logistics Agency Troop Support Medical, which supports the medical supply needs of the U.S. Department...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of TAKHZYRO 300 MG/2 ML SYRINGE 2ML. The contract is a delivery order with a firm fixed price of $48,673.20 and an ultimate completion date of August 29, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999 through December 2025 for delivering a...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,060.43 to AmerisourceBergen Drug Corp for the supply of TADLIQ 20 mg/5 ml suspension in 150ml quantities. This firm fixed-price, non-set-aside delivery order was awarded on July 31, 2025, with an ultimate completion date of August 1, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2,343.59 by the Defense Logistics Agency's Medical Supply Chain on August 13, 2025, with an ultimate completion date of September 4, 2025. The contract calls for delivery of Tezspire 210 mg/1.91 ml pen injectors, a specialty pharmaceutical product for respiratory conditions. This is a firm fixed-price, competitively awarded delivery order with no...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on June 18, 2025, by the Defense Logistics Agency (DLA) for the supply of LEQVIO 284 mg/1.5 mL syringes with a ceiling value of $16,278.85. This firm fixed-price delivery order, which is scheduled for completion by July 11, 2025, is unset-aside and competitively awarded. The award represents a continuation of the company's substantial role as a critical...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of LEQVIO 284 mg/1.5 mL syringes, with a ceiling value of $2,325.55. This is a firm fixed-price delivery order without set-aside designation, reflecting a competitively awarded procurement. The contract specifies performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order represents a...
- The Defense Logistics Agency awarded a delivery order valued at $1,430.07 to AmerisourceBergen Drug Corp for the supply of Actemra 162 mg/0.9 mL syringes on September 2, 2025, with completion targeted for September 3, 2025. This firm fixed-price delivery order, which carries no set-aside designation, will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. The award represents a competitively awarded transaction under AmerisourceBergen's existing contract vehicle with the...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB25FEHPEDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $34,342.56 to AmerisourceBergen Drug Corp for the supply of Takhzyro 300 mg/2 mL syringes on September 15, 2025. This firm fixed-price, competitively awarded contract represents a non-set-aside procurement and is scheduled for completion by October 6, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery order from its corporate office location in the same city. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. AmerisourceBergen's demonstrated capability in meeting federal procurement requirements through open competition, combined with its extensive portfolio of pharmaceutical deliveries across multiple therapeutic domains, positions it as a critical vendor in the federal medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $34.3k | 9/15/25 |